BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37648302)

  • 1. Pre-operative Plasma Fibrinogen Level as a Potential Predictor of Pathological T3 Upstaging in Clinically Localized Renal Cell Carcinoma.
    Sekito S; Tanaka S; Kitano G; Kato M; Ogura Y; Kojima T
    Anticancer Res; 2023 Sep; 43(9):4229-4235. PubMed ID: 37648302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncological outcomes and pathological characteristics of cT1 upstaging to pT3a renal cell carcinoma compared with de novo pT3a tumors.
    Senguttuvan Karthikeyan V; Mallya A; Sivaraman A; Galiano M; Rozet F; Cathala N; Barret E; Mombet A; Prapotnich D; Sanchez-Salas R; Cathelineau X
    Actas Urol Esp (Engl Ed); 2019 Jun; 43(5):234-240. PubMed ID: 30857765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel nomogram can predict pathological T3a upstaged from clinical T1a in localized renal cell carcinoma.
    Cao C; Kang X; Shang B; Shou J; Shi H; Jiang W; Xie R; Zhang J; Zhang L; Zheng S; Bi X; Li C; Ma J
    Int Braz J Urol; 2022; 48(5):784-794. PubMed ID: 35838503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perioperative morbidity, oncological outcomes and predictors of pT3a upstaging for patients undergoing partial nephrectomy for cT1 tumors.
    Mouracade P; Kara O; Dagenais J; Maurice MJ; Nelson RJ; Malkoc E; Kaouk JH
    World J Urol; 2017 Sep; 35(9):1425-1433. PubMed ID: 28197727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient and tumor characteristics of histological subtypes of renal cell carcinoma and its risk of upstaging to ≥pT3.
    Wenzel M; Hoeh B; Cano Garcia C; Bernatz S; Köllermann J; Kluth LA; Chun FKH; Becker A; Mandel P
    Urol Oncol; 2023 Dec; 41(12):487.e7-487.e13. PubMed ID: 37758628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes and predictors of clinical T1 to pathological T3a tumor up-staging after robotic partial nephrectomy: a multi-institutional analysis.
    Gorin MA; Ball MW; Pierorazio PM; Tanagho YS; Bhayani SB; Kaouk JH; Rogers CG; Stifelman MD; Khalifeh A; Kumar R; Sivarajan G; Allaf ME
    J Urol; 2013 Nov; 190(5):1907-11. PubMed ID: 23764083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological Upstaging of Clinical T1 to Pathological T3a Renal Cell Carcinoma: A Multi-institutional Analysis of Short-term Outcomes.
    Nayak JG; Patel P; Saarela O; Liu Z; Kapoor A; Finelli A; Tanguay S; Rendon R; Moore R; Black PC; Lacombe L; Breau RH; Kawakami J; Drachenberg DE
    Urology; 2016 Aug; 94():154-60. PubMed ID: 27041471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of renal tumor contour irregularity score in pathological T3a upstaging of clinical T1 renal cell carcinoma: A multi-institutional study.
    Xu P; Zhang S; Cao B; Li Y; Huang J; Lin W; Cheng J; Li H; Chen W; Zhu Y; Jiang S; Hu X; Wu J; Wu Z; Zhou J; Guo J; Wang H
    Urol Oncol; 2022 May; 40(5):199.e1-199.e8. PubMed ID: 35365414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathological T3a Upstaging of Clinical T1 Renal Cell Carcinoma: Outcomes According to Surgical Technique and Predictors of Upstaging.
    Jeong SH; Kim JK; Park J; Jeon HJ; Yoon MY; Jeong CW; Ku JH; Kim HH; Kwak C
    PLoS One; 2016; 11(11):e0166183. PubMed ID: 27861519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Predictor of Survival with Renal Cell Carcinoma After Nephrectomy.
    Peng D; He ZS; Li XS; Tang Q; Zhang L; Yang KW; Yu XT; Zhang CJ; Zhou LQ
    J Endourol; 2017 Apr; 31(4):397-404. PubMed ID: 28121179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High R.E.N.A.L. Nephrometry scores are associated with pathologic upstaging of clinical T1 renal-cell carcinomas in radical nephrectomy specimens: implications for nephron-sparing surgery.
    Tay MH; Thamboo TP; Wu FM; Zhaojin C; Choo TB; Ramaan L; Tiong HY
    J Endourol; 2014 Sep; 28(9):1138-42. PubMed ID: 24810993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High preoperative plasma fibrinogen is an independent predictor of distant metastasis and poor prognosis in renal cell carcinoma.
    Du J; Zheng JH; Chen XS; Yang Q; Zhang YH; Zhou L; Yao X
    Int J Clin Oncol; 2013 Jun; 18(3):517-23. PubMed ID: 22610754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of plasma fibrinogen levels in patients with localized upper tract urothelial carcinoma.
    Tanaka N; Kikuchi E; Matsumoto K; Hayakawa N; Ide H; Miyajima A; Nakamura S; Oya M
    BJU Int; 2013 May; 111(6):857-64. PubMed ID: 22757942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with pathological tumor stage and T3a upstage in clinical T1-2 renal cell carcinoma.
    Kalfazade N; Özlü DN; Şam E; Akkaş F; Gürbüz N
    Prog Urol; 2023 Mar; 33(3):135-144. PubMed ID: 36604246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A morphology-based nephrometry score to predict pathological upstaging to T3 renal cell carcinoma.
    Zhang W; Shi H; Yang Y; Xiao C; Nian X; Gao Y; Liu W; Pang Q; Shi X
    Transl Androl Urol; 2022 Dec; 11(12):1645-1654. PubMed ID: 36632158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of delaying radical nephrectomy for stage II or higher renal cell carcinoma.
    Kim KH; You D; Jeong IG; Song C; Hong JH; Ahn H; Kim CS
    J Cancer Res Clin Oncol; 2012 Sep; 138(9):1561-7. PubMed ID: 22547152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive factors for recurrence after partial nephrectomy for clinical T1 renal cell carcinoma: a retrospective study of 1227 cases from a single institution.
    Takagi T; Yoshida K; Wada A; Kondo T; Fukuda H; Ishihara H; Kobayashi H; Iizuka J; Okumi M; Ishida H; Nagashima Y; Tanabe K
    Int J Clin Oncol; 2020 May; 25(5):892-898. PubMed ID: 32048086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical impact of segmental renal vein invasion on recurrence in patients with clinical T1 renal cell carcinoma undergoing partial nephrectomy.
    Yoshida T; Ohe C; Tsuzuki T; Sugi M; Kinoshita H; Tsuta K; Matsuda T
    Int J Clin Oncol; 2020 Mar; 25(3):464-471. PubMed ID: 31531786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does renal tumor biopsies for small renal carcinoma increase the risk of upstaging on final surgery pathology report and the risk of recurrence?
    Asselin C; Finelli A; Breau RH; Mallick R; Kapoor A; Rendon RA; Tanguay S; Pouliot F; Fairey A; Lavallée LT; Bladou F; Kawakami J; So AI; Richard PO
    Urol Oncol; 2020 Oct; 38(10):798.e9-798.e16. PubMed ID: 32693974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of pathologic stage T3a renal cell carcinoma up-staged from small renal tumor: emphasis on partial nephrectomy.
    Lee H; Lee M; Lee SE; Byun SS; Kim HH; Kwak C; Hong SK
    BMC Cancer; 2018 Apr; 18(1):427. PubMed ID: 29661179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.